Founded in 2004, MCRA is a leading adviser and clinical research organization serving the neuro-musculoskeletal and medical device industries. MCRA’s unique value lies in its industry experience together with its successful integration of five business value creators: regulatory, reimbursement, clinical research, healthcare compliance, and quality assurance. MCRA serves nearly 500 clients globally from its offices in Washington, DC, Manchester, Conn., and New York, N.Y.
Caltius Structured Capital made a junior capital investment in MCRA to help management accelerate its successful growth strategy. CSC made two follow-on investments in 2018 to continue to support the company’s growth. CSC agented a third follow-on investment in May 2019, then made an additional direct investment in December 2019.
“It has been a pleasure getting to know the Caltius team and we are excited about our opportunities with their well-structured junior capital investment. The right capital partner is very important to us, and Caltius quickly demonstrated their extensive relevant experience investing growth capital in companies like MCRA.”
David Lown, General Manager, MCRA